HeartSciences (HSCS) Proxy filing summary

Executive summary

• Supplemental materials concern the proposed transaction and include a social media post reposted by a DCG executive.

• A Cointelegraph post cited Bitwise’s Matt Hougan: the median top-20 crypto asset was down 15% YTD, while the equal-weight average was up 14%, with HYPE and ZEC among the winners.

Voting matters and shareholder proposals

• Shareholder approval is a condition to closing; eligible holders were mailed the definitive proxy statement and proxy card for the special meeting.

• Potential proxy-solicitation participants include directors and executive officers of both transaction parties and certain DCG executive officers; their interests are described in the definitive proxy statement.

Risk oversight and compliance

• Closing may be delayed or fail if conditions are unmet; other risks include market conditions, integration, management of a newly public entity, and Zcash and broader digital-asset volatility and uncertainty.

• Forward-looking statements reflect current expectations, are subject to known and unknown risks, and are not subject to an update obligation except as required by law.